Q4 2023 Holdings
Filed 2024-02-08 | 7 holdings | $388.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| RayzeBio, Inc. | Common Stock | 75525N107 | $320.7M | 5,158,161 | 82.5% |
| Crispr Therapeutics AG(CRSP) | Common Shares | H17182108 | $31.2M | 498,558 | 8.0% |
| Repare Therapeutics, Inc.(RPTX) | Common Stock | 760273102 | $19.3M | 2,646,657 | 5.0% |
| Gritstone Bio, Inc.(2JQ) | Common Stock | 39868T105 | $7.3M | 3,561,150 | 1.9% |
| Passage Bio, Inc. | Common Stock | 702712100 | $5.0M | 4,959,769 | 1.3% |
| Adverum Biotechnologies, Inc.(ADVMCHF) | Common Stock | 00773U108 | $3.8M | 5,068,233 | 1.0% |
| Aligos Therapeutics, Inc. | Common Stock | 01626L105 | $1.5M | 2,320,381 | 0.4% |